Sarepta Therapeutics | GJELD

Debt Endring Dato
Acadia Pharmaceuticals USD 59.64M 59.64M 2024-03
Agios Pharmaceuticals USD 68.35M 67.21M 2024-03
Alnylam Pharmaceuticals USD 1.3B 280.46M 2024-03
Amgen USD 64.02B 593M 2024-03
Avrobio USD 224K 15.13M 2024-03
Biogen USD 6.95B 8.4M 2024-03
BioMarin Pharmaceutical USD 1.1B 9.56M 2024-03
Daiichi Sankyo JPY 101.81B 95M 2023-12
Eli Lilly USD 26.21B 6.04B 2024-03
Gilead Sciences USD 25.19B 212M 2024-03
Incyte USD 37.39M 4.79M 2024-03
Insmed USD 1.21B 25.76M 2024-03
Ionis Pharmaceuticals USD 1.44B 169.41M 2024-03
Moderna USD 1.24B 662M 2024-03
Neurocrine Biosciences USD 511.9M 342M 2024-03
Pfizer USD 68.71B 5.11B 2024-03
PTC Therapeutics USD 421.44M 1.7B 2024-03
Regeneron Pharmaceuticals USD 2.7B 400K 2024-03
Roche Holding CHF 29.21B 3.82B 2023-12
Sarepta Therapeutics USD 1.38B 142.59M 2024-03
Ultragenyx Pharmaceutical USD 40.76M 40.76M 2024-03
Vertex Pharmaceuticals USD 721.3M 331M 2024-03



Sarepta Therapeutics GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.